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Abstract 
This paper reviews the use of iron oxide nanoparticle-nanofibre composites in 
tissue engineering with a focus on the electrospinning technique. Electrospinning 
is an established method of scaffold fabrication offering a number of key 
advantages which include its facile nature, with electrospun materials offering a 
high surface area to volume ratio, potential for the release of drugs and 
antimicrobials, controllable fibre diameters and high porosity and permeability. A 
number of different techniques for the preparation of iron oxide nanoparticles 
including their functionalisation are discussed along with their applications in the 
biomedical field. The review then focusses on the fabrication of nanoparticle-
nanofibre composite scaffolds formed using electrospinning. The advantages and 
disadvantages of current fabrication techniques are discussed including the 
fabrication of nanofibres using pre-synthesised nanoparticles and post-treatment 
synthesised nanoparticles. We demonstrate that emerging in-situ synthesis 
techniques show promise by offering a reduced number of steps and simpler 
procedures for the production of magnetic scaffolds.  These scaffolds have a 
number of applications in tissue engineering, allowing for improved bone and 
tissue repair. 
1. Introduction 
Tissue engineering has made great advances in recent years combining both 
engineering and biology to repair, replace or regenerate parts of or whole 
tissue(s). Naturally, the applications of such technologies in medical science have 
the potential to treat a wide range of conditions. Many fundamental components of 
biological systems, including the extracellular matrix, exist and function at the 
nanoscale with sizes measured in billionths of a metre. Thus, technologies that can 
create nanoscale materials are essential in shaping and controlling systems that 
are designed to mimic tissue chemical and physical environments. 
Electrospinning is a fabrication technique that has become one the preferred 
jetting methodologies for the fabrication of tissue engineering scaffolds (1–3). It is 
an established method for fabrication of polymer constructs that offers many 
advantages to tissue engineering that include the formation of nanoscale fibres, 
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which are analogues to the extra cellular matrix (ECM), the molecular architecture 
that provides structure to the tissue. In addition, electrospinning methods allow 
the incorporation of biologically active moieties into the polymer construct 
rendering the scaffold ‘smarter’. The improved functionality of scaffolds allowed 
by electrospinning coupled with recent advances in scale of manufacture have led 
to a resurgence of interest in electrospinning. The incorporation of nanoparticles 
within electrospun fibres is a further method by which improved functionality can 
be programmed into polymer nanofibers. A key example of such improved 
functionality is magnetic scaffolds, where iron oxide nanoparticles (IONPs) are 
incorporated into scaffold structures for applications in tissue engineering, drug 
delivery and wound healing. This review will firstly discuss tissue engineering 
scaffolds and the techniques used for their fabrication, and then review the 
applications of IONPs before focussing on the development of iron oxide 
nanoparticle-nanofibre composites using electrospinning and review their 
potential applications. 
 
2. Tissue Engineering scaffolds 
Tissue engineering scaffolds require four key properties to allow them to support 
the three-dimensional formation of viable tissue (4). These are biocompatibility, 
biodegradability, tensile strength and scaffold architecture. The scaffold must 
provide a biocompatible 3D matrix supporting or enhancing cell proliferation and 
migration while allowing the uninhibited diffusion of nutrients and other cell 
media throughout the structure. It must also be compatible with the human body, 
without triggering an immune response when implanted.  The material used must 
be biodegradable to allow the scaffold to degrade as the cells begin to form their 
own matrix. The mechanical properties of the scaffold should match that of the 
tissue in which the scaffold will be introduced (5). For example, in tissue 
engineered cartilage and bone, the scaffold will require specific tensile and 
compression strengths to withstand the load placed upon it by the patient without 
“shielding” osteoblast cells causing bone resorption (6). The overall scaffold 
architecture is also key, for example the axons of neurons require directional 
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growth and therefore scaffolds comprised of uniaxial fibre arrays have been shown 
to result in improved axonal outgrowth parallel to the direction of the fibres (7). 
This is also true for myocytes (8). Finally, the overall nonwoven structure requires 
a high degree of porosity, with a sufficient minimum pore size to allow the 
proliferation of cells and diffusion of cell media, cell-signalling stimuli, waste 
products and other required substances (4). Cell signalling, the communication 
between proximal cells, is also of great importance for tissue growth. It has been 
reported that porosity, pore size, interconnectivity and tensile strength  are all 
important influences of cell signalling and differentiation (9). 
Several different methods exist to produce scaffolds for tissue engineering. Most 
common are jetting methodologies such as aerodynamically assisted 
jetting/threading, pressure assisted/driven jetting/spinning (10), laser guided 
writing (11), inkjet printing (12), electrospraying (13) and electrospinning (14). 
Laser guided writing and ink jet printing have historically dominated the field, 
contributing much to the recognition of jetting technologies and their application 
(10). However, due to their micron-scale size fabrication limits which are much 
larger than the natural ECM they are designed to mimic, these technologies do not 
translate easily into the development of constructs for clinical application. Other 
methods such as electrospraying and electrospinning are currently undergoing a 
widespread revival of scientific investigation of chemical, physical and biological 
outputs achievable and are able to produce structures more similar in size to the 
natural ECM. These techniques have generated much scientific and commercial 
interest in fields such as tissue engineering, regenerative devices and drug 
delivery. 
 
3. Electrospinning 
The advantages of electrospinning for the fabrication of non-woven fibrous 
structures has meant that it has been applied in a diverse range of fields from 
regenerative medicine to filtration and water treatment (10,14–19). An 
electrospun scaffold can offer a number of desirable properties such as a high 
surface area to volume ratio, potential for the release of drugs and antimicrobials, 
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controllable fibre diameters, high porosity and permeability. In more recent years 
the emergence of new electrospinning technologies has ensured that fabrication is 
scalable and economically viable for high volume production.  
Figure 1 is a schematic representation of the needle based electrospinning process. 
Electrospinning uses a high voltage power supply to create a large potential 
difference between a grounded “collector” structure and a polymer solution or 
melt being delivered at a constant rate through an aperture, such as a blunt end 
needle. As the voltage is increased the body of the polymer fluid becomes charged 
and electrostatic repulsion directly opposes surface tension, resulting in the 
normally spherical droplet at the aperture distending into a conical shape. This 
cone is referred to as the “Taylor” cone, after Sir Geoffrey Taylor who first 
mathematically modelled the phenomenon (20,21). At a critical voltage the 
electrostatic attractive force between the solution and the collector causes a jet of 
polymer solution to be expelled from the cone tip towards the grounded collector 
surface. This jet then undergoes a whipping instability and dries in flight as the 
solvent evaporates, depositing the nanofibres on the collector (14). 
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Figure 1. A Schematic diagram of electrospinning apparatus in (a) a vertical set up 
and (b) a horizontal set up. Reprinted from Biotechnology Advances, Volume 28, 
Issue 3, Nandana Bhardwaj, Subhas C. Kundu, Electrospinning: A fascinating fiber 
fabrication technique, Pages 325 - 347, Copyright (2010), with permission from 
Elsevier (14). 
 
Despite the relative simplicity of the equipment involved, by carefully controlling 
processing parameters the fibre’s diameters, orientations, total mat porosity and 
other properties can be controlled, allowing optimisation of the mat for a given 
application. In addition, the technique’s ability to work with a wide variety of 
materials allows a range of specific biological, mechanical or chemical properties 
to be achieved (15). Therefore by controlling solution properties such as the 
viscosity, conductivity, molecular weight and surface tension along with 
processing parameters such as the applied electrical field, distance from the 
syringe tip to the collector and flow rate of the polymer solution,  a range of 
desirable characteristics can be attributed to the nanofibres (14). 
Further to these controllable variables it has been shown that by modifying the 
collector architecture, for example by using two parallel conductive substrates of 
varying gap size, fibres can be aligned uniaxially into arrays (22). This alignment of 
fibres has led to anisotropic mat properties in terms of tensile strength as well as 
directional cell growth, as previously discussed. Further modifications to the 
collector have been illustrated to expand the possible fibre orientations including 
rotating drum electrode (23) and knife-edge collectors (24). Furthermore, 
“coaxial” electrospinning allows for a more complex fibre architecture, forming a 
fibre comprised of two non-mixed materials in a core-sheath arrangement (25,26).  
Although needle based electrospinning allows excellent control over both fibre 
diameter and their composition it has an extremely low throughput where basic 
systems are limited to flow rates of less than 0.5 mL per hour. A free-surface 
electrospinning arrangement such as the El Marco NanoSpider™ system is capable 
of forming fibres with throughput many hundreds of times greater than the 
conventional needle based electrospinning set up (27,28). In the free-surface 
electrospinning approach the spinning solution is simply held in a bath, rather 
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than being delivered through an aperture, with the whole bath then being 
connected to a high voltage power supply (Figure 2). In the specific case of the 
NanoSpider™ a rotating metal mandrel is half-submerged in the bath to 
concentrate the electric field on the thin layer of polymer which coats the mandrel. 
In this process many Taylor cones are formed on the surface of the polymer 
solution, and electrospinning upwards onto a collector above the bath. This 
increases the throughput of the process many hundreds of times above the 
conventional needle-based system, however much higher voltages, up to 82kV in 
the case of the NanoSpider™ are required and solution properties such as viscosity, 
conductivity and surface tension must be more tightly controlled (29). This is due 
to requirement of the Taylor cone to form upwards and the inability to control the 
feed rate and subsequent Taylor cone formation. There is also an absence of a 
point at which to concentrate the electric field (such as in a blunt end needle) 
which results in a higher initiation voltage. 
 
 
Figure 2. A schematic diagram showing a free-surface electrospinning set-up. A 
polymer solution/melt is held in a bath and a spinning electrode connected to a high 
voltage power supply is utilized to form multiple jets. Nanofibers are electrospun 
upwards and collected on a grounded collector plate.. Reprinted from Materials 
Science and Engineering: C, Volume 70, Part 1, 1 January 2017, Pages 512-519, Luke 
Burke, Chris J. Mortimer, Daniel J. Curtis, Aled R. Lewis, Rhodri Williams, Karl 
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Hawkins, Thierry G.G. Maffeis, Chris J. Wright, In-situ synthesis of magnetic iron-oxide 
nanoparticle-nanofibre composites using electrospinning, Copyright (2017), with 
permission from Elsevier (28). 
 
Electrospun scaffolds have seen a vast amount of research in the tissue 
engineering field. This is due to the requirement of the scaffold to have an 
appropriate pore size and porosity to allow the proliferation of cells as well as a 
large surface area to volume ratio to promote cell adhesion, growth migration and 
differentiation (30). 
In a recent review, we discuss the importance of understanding the interactions 
between not only eukaryotic cells but also bacteria for the development of tissue 
engineering scaffolds as cells need to compete with bacteria in many environments 
therefore the ideal tissue engineering scaffold will promote cell adhesion while 
inhibiting bacterial cell adhesion (31). Although there has been little research to 
date, interactions of bacteria with nanofibres and nano-structured surface have 
been shown to be similar. A smaller fibre diameter is favourable since scaffolds 
with nanofibre diameters smaller than the bacteria have been shown to be less 
susceptible to bacterial adhesion and fouling (31). Furthermore, the inclusion of an 
active antimicrobial ingredient can further inhibit bacterial colonisation and aid in 
the promotion of cell adhesion. 
 
4. Iron Oxide Nanoparticles 
Iron oxide is known to exist in sixteen forms as oxides, hydroxides or oxide-
hydroxides (32). There are six non-hydrated crystalline iron oxide phases which 
have been identified so far, which are classified according to the valence state of 
iron in their crystal structure (33). Among these the most of interest in biomedical 
fields are magnetite (Fe3O4) and maghemite (γ-Fe2O3) due to their functionality 
and favourable magnetic properties (33). Figure 2 shows the crystal structure and 
crystallographic data of hematite, magnetite and maghemite. Magnetite, Fe3O4, is a 
black ferromagnetic material with an inverse spinel structure. It contains both Fe2+ 
and Fe3+. Maghemite, γ-Fe2O3, is a redish-brown ferromagnetic material which is 
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isostructural with magnetite, but with cation deficient sites.  An important 
structural properties of both magnetite and maghemite is its crystal size. If the 
diameter of the nanoparticles are smaller than 20nm they display 
superparamagnetism, resulting in the particles showing no continuing magnetic 
interaction upon the removal of an external magnetic field (34). Furthermore iron 
oxide has been reported as non-toxic at low doses, biodegradable and 
biocompatible (35). 
 
Figure 3. Crystal structure and crystallographic data of hematite, magnetite and 
maghemite (the black ball is Fe2+, the green ball is Fe3+ and the red ball is O2−). 
Reprinted with permission from (36). 
Both magnetite and maghemite exhibit ferrimagnetism at room temperature. Many 
of the properties of IONPs are dependent on both their size and shape (32). 
 
4.1.1 Nanoparticle Synthesis 
A number of different synthesis techniques have been applied to produce magnetic 
iron oxide nanoparticles (IONPs) including co-precipitation, thermal 
decomposition, hydrothermal and solvothermal syntheses, sol-gel synthesis, 
microemulsion, ultrasound irradiation and biological synthesis. These methods 
include both aqueous and non-aqueous techniques with the former usually 
preferred due to the lower cost and sustainability (37). 
Co-precipitation and thermal decomposition are the most commonly applied 
methods for preparing iron oxide nanoparticle-nanofibre composites, particularly 
for post-treatment and in-situ synthesis techniques. 
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4.1.2 Co-precipitation 
Co-precipitation is considered the most conventional method. Generally, a basic 
solution is prepared containing a 1:2 molar ratio of ferric and ferrous ions. A 
suitable reducing agent can be used leading to the reaction shown in equation 
4.1.1. 
Fe2+ + 2Fe3+ + 8OH− ⇆ Fe(OH)2 + 2Fe(OH)3 → Fe3O4↓ + 4H2O        Equation 4.1.1 
 
Due to the nature of the technique, particle aggregation is a major drawback (38). 
To overcome this problem researchers have introduced surfactants and 
biomolecules into the process to reduce the likelihood of aggregation and maintain 
a small particle diameter. Salavanti-Niasari et al. used a co-precipitation method in 
the presence of octanoic acid, a surfactant, obtaining magnetite nanoparticles of 
average diameter 25nm (39). Magnetic chitosan coated magnetite nanoparticles 
were prepared by Liu et al. using a co-precipitation method (40). Suh et al. 
presented an in situ synthesis technique for the production of non-spherical 
magnetic iron oxide nanoparticles in a carboxyl functionalised polymer matrix 
(41). 
 
4.1.3 Thermal Decomposition 
Thermal decomposition is a particle formation technique with slower production 
rates than co-precipitation but offers more control over particle size and size 
distribution. The thermal decomposition technique can generally be sub-divided 
into hot-injection strategies where the precursors are injected into a hot reaction 
mixture, and conventional reaction strategies where a reaction mixture is 
prepared at room temperature and then heated in a closed or open reaction vessel 
(37). IONPs formed using thermal decomposition have a narrow size distribution 
and high crystallinity when compared to particles formed using a co-precipitation 
technique. A number of different ferric salts are used including iron pentacarbonyl 
(42), iron (III) acetylacetonate (43), iron oleate (44), ferrocene (45) and triiron 
dodecacarbonyl (46). Organic molecules are often added to the reaction process as 
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stabilisers which can slow down the nucleation process and favour the formation 
of small IONPs. 
 
4.2 Biomedical Applications 
The biocompatibility and low toxicity of iron oxide nanoparticles makes them ideal 
candidates for applications in the biomedical field. It is established that the iron 
oxide nanoparticles themselves are biocompatible and are excreted naturally by 
the liver when released into the body at low doses (47). There are a number of in 
vivo applications which can generally be grouped into three categories; (1) 
magnetic vectors guided to a certain location using a magnetic field (2) contrast 
agent in MRI and (3) hyperthermia agent for thermoablation (Figure 3). Of 
important interest is their superparamagnetic properties which allow them to be 
used for drug delivery and also improved tissue and bone repair in tissue 
engineering. Growth factors can be attached to a magnetic carrier and guided to 
the site of a tissue engineering scaffold containing iron oxide nanoparticles which 
can improve tissue and bone repair (48–50). It has also been shown that a static 
magnetic field can improve bone repair in rabbit models. This will be discussed in 
more detail in section 6.1. 
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Figure 4. Schematic representation of biomedical and biotechnological applications 
of IONPs. Reprinted from Biotechnology Advances, Volume 33, Issue 6, Part 2, 1 
November 2015,   Katerina Hola, Zdenka Markova, Giorgio Zoppellaro, Jiri Tucek, 
Radek Zboril, Tailored functionalization of iron oxide nanoparticles for MRI, drug 
delivery, magnetic separation and immobilization of biosubstances, Pages 1162-
1176, Copyright (2010), with permission from Elsevier (33). 
 
4.2.1 Drug Delivery 
One of the major drawbacks with the use of chemotherapeutic drugs is the 
frequency and severity of side effects observed due to their systemic application. 
IONPs are of interest for use in the targeted delivery of these, and other, drugs 
(51–53). Drug delivery is a pharmaceutical approach to transporting drugs to a 
desired location in the body, often reducing the required dose. In general, magnetic 
IONPs used for drug delivery consist of a core-shell structure with the IONPs as the 
core, coated in a biocompatible component (36). The magnetic properties allow 
the pharmaceutically functionalised nanoparticles to be delivered to the site of 
interest by application of a magnetic field to a specific region of the body. 
A further application in cancer therapies is in thermoablation where local 
overheating of the cancer cells can be achieved by hyperthermia (54). 
Hyperthermia can be achieved due to the ability of magnetic nanoparticles to 
adsorb alternating current (AC) energy and convert it to heat (33). By heating to a 
temperature between 41˚C and 46˚C thermal stress can cause the cancer cells to 
undergo apoptosis, a programmed cell death.  
 
4.2.2 MRI contrast agent 
Magnetic resonance imaging (MRI) is a non-invasive diagnostic technique which is 
often the preferred imaging technique due to its high spatial resolution (~100nm), 
long effective imaging window, the absence of exposure to ionising radiation and 
rapid in vivo image acquisition (55) MRI contrast agents contain paramagnetic or 
superparamagnetic metal ions which have a positive effect on the MRI signal 
properties of surrounding tissue (56). Superparamagnetic IONPs (SPIONs) are 
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capable of substantially altering the spin-spin relaxation of water molecules (T2 
relaxation) near the magnetic nanoparticles which can enhance the negative 
contract of the image (56). The biocompatibility of IONPs makes them the 
preferred contrast agents over other metal oxides. 
4.2.3 Antibacterial Agent 
Metal oxide nanoparticles have been shown to interact with the cell membrane of 
bacteria by electrostatic interaction, inducing toxic oxidative stress on the bacteria 
by free radical formation; the reactive oxygen species (ROS) (57,58). Iron oxide 
nanoparticles have been shown to impart antimicrobial properties against both 
Gram-negative and Gram-positive bacteria. Ismail et al. synthesised maghemite 
nanoparticles of diameter 50 – 110nm by pulsed laser ablation and an agar well 
diffusion assay was used to assess the antibacterial activity (59). Inhibition zones 
were present for all Gram-negative (Pseudomonas aeruginosa, Escherichia coli and 
Serratia marcescens) and Gram-positive (Staphylococcus aureus) bacteria tested. 
 
5. Nanoparticle-nanofibre composite fabrication 
There are currently a number of different techniques employed to obtain iron 
oxide nanoparticle-nanofibre composites. These can be grouped into three 
categories; (1)pre-synthesised IONPs, (2) Post-treatment synthesised IONPs and 
(3) in-situ synthesised IONPs. Nanoparticles (NPs) are more commonly 
synthesised before electrospinning or precursors are electrospun and the 
consequent nanofibres are treated to synthesise the nanoparticles within the 
nanofibres. More recently, in-situ synthesis techniques have emerged which allow 
for NPs to be synthesised during the electrospinning process or in the solution to 
be electrospun with no pre-processing of NPs. 
The electrospinning process is generally unchanged with all particle synthesis 
techniques. If particles are pre-synthesised a co-electrospinning technique is 
generally employed where the nanoparticles are dispersed in a polymer solution 
before electrospinning. The other technique which can be used is coaxial 
electrospinning as discussed in section 3. 
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5.1 Pre-synthesised nanoparticles 
Electrospinning NPs which have already been synthesised is the most basic and 
therefore most commonly used technique for the fabrication of nanoparticle-
nanofibre composites. However, this process can often be multi-stage and time 
consuming requiring particles to be pre-synthesised and subsequently 
functionalised to reduce the effects of particle agglomeration and allow 
homogenous distribution throughout the nanofibres. 
The particle synthesis techniques employed are as outlined in section 3.1, with an 
additional functionalisation stage if necessary. Wang et al. used a co-precipitation 
technique with the reduction of iron(III) chloride hexadydrate and iron(II) 
chloride tetrahydrate using ammonium hydroxide in the presence of a graft 
copolymer to arrest the growth of NPs and prevent aggregation (60). IONPs were 
then added to solutions of PEO and PVA before electrospinning using a needle 
electrospinnning set-up. Amarjargal et al. presented an alternative technique 
where magnetite nanoparticles (MNPs) were prepared  using a modified 
precipitation method followed by a dyrothermal treatment (61). Polyurethane 
(PU) nanofibres were electrospun and superparamagnetic iron oxide 
nanoparticles (SPIONS) were assembled on the nanofibres using a facile polyol 
immersion technique. The nanofibrous mats were immersed in a colloidal solution 
containing the SPIONs under vigorous shaking at 60˚C. Ahn et al. acquired IONPs, 
separated out the SPIONs and dispersed them in a Poly(ethylene terephthatlate) 
(PET) solution before electrospinning using a needle electrospinning set-up (62). 
Ting Tan et al. prepared MNPs in an aqueous solution in the presence of a surface-
active agent to supress aggregation (63). MNPs were exposed to air for a period of 
time to allow them to oxidise to maghemite before dispersion in poly(hydroxyethyl 
methacrylate) (PHEMA) and poly-l-lactide (PLLA) solutions for needle 
electrospinning. EDX analysis confirmed the presence of iron in the fibres and 
magnetization curves show the composites to display magnetic properties 
characteristic of IONPs. Tsioptsias et al. dispersed commercially available iron(III) 
oxide NPs in a cellulose acetate solution (64). The solutions were then electrospun 
using a needle electrospinning set-up. Sung et al. fabricated  core/sheath magnetic 
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nanofibres using a coaxial electrospinning set-up (65). The core was provided by a 
magneto-rheological fluid that contained a blend of ferrofluid and mineral oil. The 
sheath was formed by Poly (ethylene terephthalate) (PET) in trifluoroacetic acid 
(TFA) and Pellethane in a co-solvent (7:3 N-N-dimethylformamide (DMF): 
dichloromethane (DCM)). The morphology was studied using SEM and TEM and 
magnetic properties analysed using magnetic curves with hysteresis loops typical 
of a superparamagnetic material. Lai et al. prepared MNPs using a high 
temperature solution phase reaction before dispersion in a Poly(lactic-co-glycolic 
acid) (PLGA) solution (66). Nanoparticle-nanofibre composites were prepared 
using electrospinning. FTIR was then used to demonstrate peaks representative of 
MNPs, DLS showed an average particle dimeter of 8.47 ± 2.12 nm and XRD 
confirmed the phase of the MNPs to be magnetite. The magnetic loops on 
magnetization curves illustrated the typical superparamagnetic behaviour of the 
MNPs. Meng et al. pre-synthesised MNPs using a modified emulsion technique and 
then  dispersed the MNPs in a solution of Poly(DL-lactide)/Dimethylacetamide 
before electrospinning (67).  
 
5.2 Post-treatment 
Post-treatment techniques involve the inclusion of a precursor in the electrospun 
nanofibres which undergo post-electrospinning processing technique to form 
IONPs within the nanofibres. Xiao et al. prepared nanofibres from PVA/PAA before 
immersion in an aqueous solution of ferrous tichloride to allow ferric cations to 
complex with free carboxyl groups on PAA through ion exchange (68). Sodium 
borohydride was then added to the mats to reduce the ferric ions to IONPs. 
Another example of post-treatment nanocomposite fabrication is the work of  
Barakat who prepared nanofibres from a solution of PVA and Iron (II) acetate 
(FeAc) (69). The nanofibre mats were dried for 24 hours before undergoing 
calcination at 700˚C for 5 hours in an argon atmosphere to form IONPs. XRD 
confirmed there was no hematite present and FTIR confirmed there was no 
magnetite present, showing that the IONPs present were maghemite. 
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5.3 In-situ synthesis 
In recent years, research has focussed on the development of in-situ synthesis 
techniques combined with electrospinning with fewer steps, more simplicity and 
lower production costs. This is an area that has been investigated in more depth 
for other metal nanoparticles. For example, Wang et al. presented a method to 
prepare silver nanoparticles dispersed in polyacrylonitrile (PAN) nanofibres 
combining a reduction reaction with electrospinning (70). Jin et al. presented a 
one-step technique to prepare silver nanoparticles in Poly(vinylpyrrolidone) PVP 
nanoparticles (71). In their study silver nitrate (AgNO3) was reduced in a 
PVP/DMF solution with DMF as the reducing agent. Solutions were then 
electrospin resulting in PVP nanofibres containing silver nanoparticles. 
Nataraj et al. presented a three-stage in-situ synthesis technique where the 
chemical reagents (FeSO4 and FeCl3) were added to a PAN solution and 
electrospun (72). The electrospun mat was then immersed in KOH for 4 hours, 
stabilised at 280˚C in air for 2 hours and carbonized at 800˚C in nitrogen 
atmosphere. XPS was used to identify the phase of the IONPs, which were 
identified as Fe2O3. Faridi-Majidi et al. present a one-stage in-situ synthesis 
technique for the electrospinning of PEO nanofibres containing IONPs (73). In their 
technique, FeCl3 and FeSO4 were added to the PEO/distilled water electrospinning 
solution. Electrospinning was carried out in an ammonia atmosphere to reduce to 
iron compounds to IONPs. SEM and TEM confirmed the nanofibrous morphology 
and presence of nanoparticles. XRD was used to identify the phase of iron oxide 
nanoparticles as maghemite.  
In a recent study we have developed a novel one-stage in-situ synthesis technique 
to fabricate PEO and PVP nanofibres containing magnetite MNPs (28). We have 
also demonstrated an ability to scale up the process from laboratory to industrial 
scale using a commercially available free-surface electrospinning set-up. In our 
technique a 2:1 molar ratio of ferric and ferrous chloride are added to a PEO 
solution in deionised water containing sodium borohydride, used to reduce the 
ions to nanoparticles. The reaction is allowed to progress before being electrospun 
(Figure 4). Nanofibre mats were crosslinked using UV irradiation, EDX was used to 
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confirm the presence of iron, DLS showed the average nanoparticle diameter to 
range from 8nm (PVP) to 26nm (PEO), XRD confirmed the phase of the 
nanoparticles to be magnetite and NMR showed a shortening in both T1 and T2 
relaxation times confirming the nanoparticles could provide a suitable relaxation 
channel. 
 
Figure 5. High magnification Scanning Transmission Electron Microscopy image of 
PEO nanofibre containing MNPs. Reprinted from Materials Science and Engineering: 
C, Volume 70, Part 1, 1 January 2017, Pages 512-519, Luke Burke, Chris J. Mortimer, 
Daniel J. Curtis, Aled R. Lewis, Rhodri Williams, Karl Hawkins, Thierry G.G. Maffeis, 
Chris J. Wright, In-situ synthesis of magnetic iron-oxide nanoparticle-nanofibre 
composites using electrospinning, Copyright (2017), with permission from Elsevier 
(28). 
 
6. Applications of iron oxide nanoparticle-nanofibre composites 
 18 
6.1 Tissue Engineering 
The incorporation of soluble factors and control of surface chemistry of tissue 
engineering scaffolds to provide biochemical cues have been well documented 
(74–76). Magnetic scaffolds have been investigated for the regeneration and repair 
of damaged or diseased tissue (50). The incorporation of MNPs into scaffolds is 
also believed to increase the rate of both bone cell growth and differentiation. This 
is due to the tissue’s ability to recognise the mechano-electrical conversion that 
can lead to increased cellular proliferation and expression levels of a number of 
genes related to bone differentiation (48,49). 
A number of different techniques have been used to fabricate magnetic scaffolds, 
however this review only focuses on those using electrospinning. Other examples 
can be found here (77–83). Bock et al. prepared magnetic scaffolds from 
hydroxyapatite/collagen dipped in a dispersion of magnetite nanoparticles (82). 
Their studies indicate the ability of the scaffolds to support adhesion and 
proliferation of human bone marrow stem cells in vitro. Lai et al. fabricated 
superparamagnetic nano-composite scaffolds for promoting bone cell proliferation 
and defect reparation (66). MNPs were prepared and electrospun into PLGA 
nanofibres of average diameter 400-600nm. Rosc17/2.8 (osteosarcoma cell lines) 
and MC3T3-E1 (osteoblast precursor cell lines) were used for their studies. They 
found that PLGA scaffolds containing MNPs promoted faster and better cell 
attachment when compared with the PLGA control.  It was also found that in the 
presence of MNPs cells proliferated significantly faster than in the PLGA control. 
Meng et al. reported that the presence of an electrospun nanofibrous material 
containing MNPs inserted within a bone fracture site in a rabbit model increased 
osteocalcin expression by osteoblasts and improved healing rates over 100 days 
(67). In their work, IONPs were synthesised using a modified emulsion technique 
along with hydroxyapatite nanoparticles and electrospun into PLA nanofibre 
scaffolds. This study used the MNPs as an intrinsic component of the scaffold to 
produce huge amounts of miniature magnetic force under an external magnetic 
field allowing continual stimulation of osteoblast cell proliferation and secretion of 
ECM.  Their studies showed that under an external magnetic field the scaffolds 
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induced earlier and higher amounts of osteocalcin positive cells in-situ, which led 
to an earlier and faster bone formation in the defect. This was evidenced by the 
faster achievement of cortical bone and medullar cavity continuity along with 
pathological observations when compared to those without the presence of a 
magnetic field. These results are a strong indication that continuous weak 
magnetic force stimulation has a significant effect on bone regeneration and repair, 
which they achieved by applying an external magnetic force to super-paramagnetic 
responsive scaffolds. Furthermore, the stimulation using the magnetic field 
resulted in a faster degradation rate of the scaffold, which is another important 
factor determining bone repair. 
Several different iron oxide nanoparticle-nanofibre composites have been 
presented for tissue engineering applications to date. The mechanism of action 
varies but in all instances the magnetic properties of the iron oxide nanoparticles 
are utilized. Generally, the magnetic properties of the scaffold are used to attract 
magnetic drug carriers, carrying growth factors which can promote adhesion and 
cell growth. Another application, as presented by Meng et al. is the use of the 
magnetic nanoparticles to provide continual stimulation to the scaffold to support 
cell adhesion and proliferation (67). This requires the use of an external magnetic 
field to provide the continuous stimulation. 
 
 
7. Conclusion 
There is a vast amount of research into potential scaffolds for tissue engineering. 
The applications of IONPs are widely reported and as such the fabrication of 
magnetic scaffolds for tissue engineering is growing rapidly, particularly in the 
area of bone tissue engineering. Electrospinning is one of the preferred methods of 
scaffold fabrication with many advantages including its ease of use and the 
capability to produce nanostructured scaffolds which can mimic the ECM. There 
are a number of different methods available for the synthesis of IONPs, some of 
which have been discussed in this review. There are also studies reported in the 
literature of the fabrication of nanoparticle-nanofibre composite scaffolds formed 
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using electrospinning. These methodologies can generally be categorised by pre-
synthesised nanoparticles, post-processed nanoparticles and nanoparticles 
synthesised in-situ. Pre-synthesised and post-processed nanoparticles are more 
commonly reported in the literature with methodologies well established. It is in-
situ synthesis techniques which have emerged more recently that show most 
promise, reducing the number of steps required and offering simple procedures 
for the production of magnetic scaffolds. 
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Figure legends 
Figure 1. A Schematic diagram of electrospinning apparatus in (a) a vertical set up and (b) 
a horizontal set up. Reprinted from Biotechnology Advances, Volume 28, Issue 3, Nandana 
Bhardwaj, Subhas C. Kundu, Electrospinning: A fascinating fiber fabrication technique, 
Pages 325 - 347, Copyright (2010), with permission from Elsevier [11]. 
Figure 2. A schematic diagram showing a free-surface electrospinning set-up. A 
polymer solution/melt is held in a bath and a spinning electrode connected to a 
high voltage power supply is utilized to form multiple jets. Nanofibers are 
electrospun upwards and collected on a grounded collector plate.. Reprinted from 
Materials Science and Engineering: C, Volume 70, Part 1, 1 January 2017, Pages 
512-519, Luke Burke, Chris J. Mortimer, Daniel J. Curtis, Aled R. Lewis, Rhodri 
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Figure 3. Crystal structure and crystallographic data of hematite, magnetite and 
maghemite (the black ball is Fe2+, the green ball is Fe3+ and the red ball is O2−). 
Reprinted with permission from [32]. 
Figure 4. Schematic representation of biomedical and biotechnological applications of 
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Figure 5. High magnification Scanning Transmission Electron Microscopy image of PEO 
nanofibre containing MNPs. Reprinted from Materials Science and Engineering: C, Volume 
70, Part 1, 1 January 2017, Pages 512-519, Luke Burke, Chris J. Mortimer, Daniel J. Curtis, 
Aled R. Lewis, Rhodri Williams, Karl Hawkins, Thierry G.G. Maffeis, Chris J. Wright, In-situ 
synthesis of magnetic iron-oxide nanoparticle-nanofibre composites using 
electrospinning, Copyright (2017), with permission from Elsevier (28). 
